KIT and melanoma: c-KIT is a type III receptor tyrosine kinase (RTK), which is involved in intracellular signaling and plays a significant role in cancer occurrence.[7] Previous studies have shown that point mutations in c-KIT result in constitutive activation of the c-KIT protein in melanoma cells, and this lead to activation of downstream proliferative and prosurvival signaling pathways.